0000899243-21-017261.txt : 20210428 0000899243-21-017261.hdr.sgml : 20210428 20210428203009 ACCESSION NUMBER: 0000899243-21-017261 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210426 FILED AS OF DATE: 20210428 DATE AS OF CHANGE: 20210428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Green John L. CENTRAL INDEX KEY: 0001709773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38443 FILM NUMBER: 21866568 MAIL ADDRESS: STREET 1: MERRIMACK PHARMACEUTICALS, INC. STREET 2: ONE KENDALL SQUARE, SUITE B7201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cogent Biosciences, Inc. CENTRAL INDEX KEY: 0001622229 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465308248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CAMBRIDGE PARK DRIVE STREET 2: SUITE 3100 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-945-5576 MAIL ADDRESS: STREET 1: 200 CAMBRIDGE PARK DRIVE STREET 2: SUITE 3100 CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: Unum Therapeutics Inc. DATE OF NAME CHANGE: 20180402 FORMER COMPANY: FORMER CONFORMED NAME: Unum Therapeutics, Inc. DATE OF NAME CHANGE: 20141014 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-26 0 0001622229 Cogent Biosciences, Inc. COGT 0001709773 Green John L. C/O COGENT BIOSCIENCES, INC. 200 CAMBRIDGE PARK DRIVE, SUITE 2500 CAMBRIDGE MA 02140 0 1 0 0 Chief Financial Officer Common Stock 2021-04-26 4 S 0 17813 8.86 D 3841 D The shares were sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units previously granted to the Reporting Person. The price reported in Column 4 was the weighted-average sale price of the shares. The shares were sold in multiple transactions at prices ranging from $8.80 to $8.90. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range set forth herein. /s/ Ryan Murr, Attorney-in-Fact 2021-04-28